Surgical Dressing Market Size, Share & Trends Analysis By Product (Primary Dressing, Secondary Dressing), By Application (Diabetes Based Surgeries, Cardiovascular Disease), By End-use (Hospitals), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global surgical dressing market size was estimated at USD 3.6 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of more than 5.56% during the forecast period. The market is majorly driven by the rising number of surgeries across the globe. For instance, as per an article published in NCBI (2020), every year, approximately 310 million major surgeries are performed worldwide; amongst which approximately 40 to 50 million are in the U.S. and 20 million in Europe. Moreover, according to a survey by the National Quality Forum, the number of surgical procedures conducted in the U.S. is increasing every year, and the rate of surgeries performed in ambulatory surgery centers has surged by 300% since the last decade. Furthermore, according to the American Society of Plastic Surgeons, approximately 18 million people in the U.S. underwent minimally invasive cosmetic surgical procedures in 2018.

Similarly, Regenexx estimated that approximately 7 million orthopedic surgeries were performed in the U.S. in 2017, out of which 242,000 adults who were below 65 years of age had a hip or knee implant. Surgeries may lead to surgical site infections if the wound is not cleaned properly. According to Infectious Disease Advisor, 5% of total surgeries performed resulted in surgical site infections. Therefore, with the increase in the number of surgeries performed, the use of surgical wound dressings is anticipated to grow during the forecasted period.

Another significant factor driving the market growth is the rising number of cardiovascular disease-related surgeries which may further increase the demand for these products. For instance, as per the data published by Europe (Eurostat), transluminal coronary angioplasties were most common in Croatia and Germany in 2018, with an average of 411 and 409 performed per 100 000 inhabitants, respectively. Furthermore, the number of bariatric surgical procedures performed is expected to increase due to the rising disease prevalence of diabetes and obesity, which may act as a driver for this industry. For instance, according to the American Society for Metabolic and Bariatric Surgery, in 2018, the total number of metabolic and bariatric procedures increased by 10.8%, i.e., from approximately 228,000 in 2017 to 252,000.

Increasing prevalence of chronic disorders, such as diabetes, is further expected to drive market growth. For instance, according to CDC’s National Diabetes Statistics report of 2020, the number of diabetes patients has increased to an estimated 34.2 million, which comprises about 10.5% of the total population. According to a similar report, an estimated 26.8 million people have been diagnosed with diabetes, whereas 7.3 million people had diabetes and were yet to be diagnosed.

Moreover, 1.5 million new cases of diabetes were diagnosed alone in 2018, which included approximately 210,000 adolescents & children younger than 20 years of age. Thus, with an increase in the number of patients suffering from diabetes, the prevalence of diabetic foot ulcers is expected to increase. According to the University of Michigan Health, there is a 15% chance for a diabetic patient to develop diabetic foot ulcers, whereas there is a 14%-24% chance for patients who develop diabetic foot ulcers to have an amputation. Wound healing in diabetes patients is slow, and wounds may cause infection if not diagnosed properly. Thus, with the increase in the number of diabetes patients, the use of surgical dressings is expected to grow, thereby aiding industry growth.

Furthermore, the growing elderly population is expected to drive growth in the global surgical dressing market. Elderly people (aged ≥65) are currently the fastest-growing group of the general population in the U.S. According to National Population Projections by the U.S. Census Bureau 2017, nearly 1 in 4 U.S. citizens is likely to be an older adult by 2060. Also, the number of older populations is expected to reach 85.67 million by 2050. The elderly population is more susceptible to chronic wounds and with an increase in age, the wound healing ability of the body slows down.

Moreover, according to Wound Care Learning Network, elderly people are more likely to be diagnosed with pressure ulcers. For instance, according to Wound Care Learning Network, 71% of patients with pressure ulcers were aged 60 & above, which highlights the vulnerability of the geriatric population to pressure ulcers. In addition, according to the Agency for Healthcare Research & Quality, more than 2.5 million people in the U.S. develop pressure ulcers every year. Thus, along with the increasing elderly population, the rising incidence of pressure ulcers amongst the populace is expected to drive the industrial scale in the times to come.

The COVID-19 pandemic had negatively impacted the market, mainly owing to the cancellation or delay of elective surgical procedures. Moreover, there was a slight impact on the number of patients visit to wound care centers, and outpatient clinics, especially in the U.S. For instance, as per the research survey published by Tissue Analytics, a Net Health company, there was an estimated 40% decline in patient visits to wound care centers during March & April 2020, as compared to 2019.

However, post-pandemic the sector is recovering gradually, as the healthcare providers have shifted to new modes of care for surgical wounds such as virtual consultations and telehealth platforms. Following the latest insights published on MobiHealthNews (HIMSS) in October 2021, the National University of Singapore in collaboration with Singapore General Hospital developed VeCare. It’s a point-of-care wound evaluation platform that comprises a smart bandage with sensors and a smartphone app for remote wound monitoring. The wearable device can detect factors of chronic wounds within 15 minutes. Furthermore, several studies have found that telemedicine options are a cost-effective way to improve wound care outcomes while also increasing patient compliance and satisfaction. The Centers for Medicare and Medicaid Services (CMS) recently updated the list of reimbursable such services. Thus, due to the aforementioned factors, the market is anticipated to gain a significant growth rate in the post-pandemic period.

Product Insights

The primary segment dominated the market with a share of more than 43.0% in 2021. This is due to an increase in demand for several primary dressing products such as hydrogels, alginates, and foam dressings, amongst others.

Foam dressing is a wound treatment that is particularly absorbent. Foam dressings require fewer changes than other forms of dressings. Foam dressings are effective for wounds with a lot of exudates, such as weeping ulcers, deep cavity wounds, wounds produced by debridement, etc. They are commonly prescribed for their most important advantage: providing a wet, warm environment that promotes healing. These dressings are typically used for full or partial-thickness wounds with moderate to extensive drainage. Furthermore, during compression therapy, these dressings act as a cushion to cover the damaged area as well as a barrier against bacteria. It is believed that the ability of these dressings to be utilized as primary or secondary dressings during accidents and other serious situations will promote their adoption.

The others segment is expected to witness expansion at the fastest CAGR of 7.01% during the forecast period. NPWT is often regarded as the best therapeutic option, particularly for deep acute wounds and persistent chronic wounds such as leg ulcers. Increased incidence of accidents and traumatic events, rising chronic wounds such as diabetic foot ulcers, and technological enhancements in NPWT devices are some of the factors driving the segment growth.

Moreover, NPWT is expected to gain a market share due to the advantages of the device such as rapid wound healing, increased patient compliance, and decreasing chances of infection in the patient. The majority of clinical investigations have indicated that this therapy is successful in the treatment of superficial wounds. Furthermore, using NPWT locally in infected wounds has benefits such as wound drainage, angiogenesis promotion, proteinase excretion, and reduced local and systemic bacterial load. As per a study published in the Journal of Trauma 2018, NPWT combined with silver dressings helps to reduce infection.

Application Insights

The cardiovascular disease (CVD) segment is expected to exhibit a  CAGR of 4.65% during the forecast period. CVD-based surgeries are expected to increase due to their increasing disease burden. It has been estimated by the WHO that over 3/4th of the deaths due to CVD occur in developing countries. The primary causes of heart disease are high junk food consumption, sedentary lifestyles, and mental stress. According to the WHO, approximately 17.9 million people die from cardiovascular diseases each year, accounting for approximately 31% of all deaths worldwide. Moreover, around 23.6 million people are expected to die from cardiovascular diseases by 2030. The rising prevalence of cardiac diseases has led to a surge in the number of CVD surgeries. For instance, according to lifespan.org data (2018), around 500,000 open-heart surgeries are performed each year in the U.S. Thus, with a rising number of cardiac surgeries a demand for surgical dressings is expected to surge significantly over the forecast period.

Diabetes based surgeries segment is expected to witness significant growth in the forecast period. The increasing incidence of diabetes and diabetic foot ulcers is a major factor driving the segment growth. For instance, according to ScienceDirect, diabetic foot ulcers may affect more than 25% of the diabetic population and may lead to amputation of the foot in 20% of patients. Moreover, according to American Diabetes Association, in 2018, an estimated 34.2 million people, i.e., 10.5% of the total U.S. population, had diabetes. Nearly, about 1.6 million U.S. residents had type 1 diabetes, which includes about 187,000 adolescents and children. Moreover, according to a similar source, approximately 1.5 million people in the U.S. are diagnosed with diabetes each year.

Currently, in the U.S., diabetic foot ulcers are responsible for more hospital admissions compared to any other diabetic complication. In addition, according to NCBI, diabetes has become a leading cause in the U.S. of nontraumatic amputation. The use of surgical wound dressing products such as hydrogels or dressings with silver and collagen are majorly used for the treatment of diabetic foot ulcers, as they allow rapid healing. Thus, with an increase in the number of patients suffering from diabetes, and a rise in the prevalence of diabetic foot ulcers, the segment is expected to impel during the forecast period.

End-use Insights

The hospital segment held the largest market share in 2021 with a share of more than 54.0%, owing to the increasing number of surgical procedures, rising incidence of diabetic foot ulcers, and increasing number of hospitals. For instance, as per the latest survey by the American Hospital Association, the total number of hospitals in the U.S. was counted to be 6,093 in 2022. Similarly, as per reports, there has been a constant increase in the number of hospitals in the U.K., as the number of hospitals has increased to 1,978 in 2019. Moreover, according to the Australian Institute of Health and Welfare, the number of hospitalizations in Australia has increased. In 2019 – 2020, 11.1 million people were hospitalized in Australia, out of which 6.7 million were hospitalized in a public hospital, whereas, 4.4 million were in private hospitals. Thus, with an increasing number of hospitals, and hospitalization cases, the segment is expected to have significant growth over the forecast period.

Along similar lines, the ambulatory centers segment is expected to grow at the fastest CAGR of 6.4% during the forecast period. Developed countries such as the U.S., and U.K. have well-equipped ambulatory surgery centers (ASCs), where surgical procedures are conducted at a more economical rate and the patients may not have to stay overnight. The range and number of ASCs are increasing in developed and developing countries, which is adding to the number of surgical procedures conducted worldwide. According to Advancing Surgical Care, as of 2021, there are 5,758 Medicare-certified ambulatory surgical centers, in the U.S. In addition, favorable reimbursement coverages are being provided with regard to services provided by ASCs. Thus, with an increase in the number of ASCs and the number of surgeries being performed, demand for surgical dressings is expected to increase and hence ASCs are a huge potential market for surgical dressings.

Regional Insights

North America held over 34.0% share and dominated the market in 2021 with the U.S. accounting for a major share. The dominance is owing to the region's improved healthcare infrastructure and an increasing number of surgical procedures. For instance, according to Life Span Organization, about 500,000 open-heart surgeries were performed in the U.S. in 2018. Moreover, according to AHA Journals, approximately, 40,000 children undergo congenital heart surgery in the U.S. As such surgeries take time to heal, advanced wound care products help in healing such wounds in a quick duration.

Similarly, an increase in the incidence of chronic wounds in the U.S. is expected to boost industry growth. For instance, according to an NCBI, approximately about 2% of the U.S. population is estimated to be affected by chronic wounds. Furthermore, firms like Cardinal Health, Coloplast A/S, Integra Lifesciences, and others have a vast portfolio of surgical dressings and have a high market share in the U.S. As a result of the aforementioned factors, the United States is likely to dominate the market.

Asia Pacific is anticipated to witness the fastest growth with a CAGR of 7.7%. The presence of developing countries such as China, India, and Japan is anticipated to boost the market growth in Asia Pacific region. Moreover, the presence of a large population base and rising disposable income are further driving the market growth in this region. In addition, the rapidly growing medical tourism industry can also be attributed to the increase in demand for surgical dressing products in this region.

Furthermore, the most important trend in the Asia advanced surgical dressings market is the significant surge in R&D initiatives. These trends are predicted to contribute to technological advancement. For instance, in July 2020, the University of South Australia developed a unique coating that contains a specific antioxidant that, when applied to any sort of wound dressing, can lower wound inflammation while breaking up infection to aid in rapid wound healing. Additionally, in August 2019, Flinders supported a USD 5.25 million research initiative in Australia with Wound Innovations and global partner Paul Hartmann Pty Ltd. The focus of this research was 'Wound Management in the Aged Care Sector,' with an emphasis on chronic illnesses like bedsores, which are more common among the elderly. These R&D advancements are projected to result in major releases of technologically better surgical wound dressings, thereby, boosting market growth potential throughout the forecast period.

Key Companies & Market Share Insights

The market is highly fragmented in nature with the presence of several small and large manufacturers. Competitive rivalry and the degree of competition in the industry are expected to intensify over the forecasted period due to the presence of many players. Furthermore, leading players are involved in collaborations, product launches, mergers & acquisitions to strengthen their product portfolios. For instance, in October 2021, Healthium Medtech Limited, a global MedTech company focused on products used in surgical, post-surgical, and chronic care, launched Trushield NXT surgical wound dressing. Reportedly, Trushield NXT combines the advantages of a 3D hydrocellular substrate and patented infection prevention technology to offer a complete wound care system that provides 360-degree wound protection. It also provides exudate and moisture management while remaining waterproof. Its patented technology continuously inhibits pathogen growth with a unique non-leaching, non-depleting kill mechanism. It has patents in the U.S., Europe, and India.

Similarly, in November 2018, MÓ§lnlycke launched Mepilex Border Flex. The new Mepilex Border Flex dressing is designed to support fewer dressing changes, lowering dressing costs and waste while promoting optimal healing. Thus, with various strategies acquired by leading players, the market is expected to impel during the forecast period. Some prominent players in the global surgical dressing market include:

• 3M

• Smith & Nephew

• Mölnlycke Health Care AB

• ConvaTec Group PLC

• Johnson & Johnson

• Baxter International

• Coloplast Corp.

• Medtronic

• Derma Sciences Inc. (Integra LifeSciences)

• Cardinal Health

Surgical Dressing Market Report Scope

Segments Covered in the Report 

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global surgical dressing market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Primary Dressing

    • Foam Dressing

    • Alginate Dressing

    • Soft Silicone Dressing

    • Composite Dressing

    • Hydrogel Dressing

    • Hydrocolloid Dressing

    • Film Dressing

  • Secondary Dressing

    • Absorbents

    • Bandages

      • Muslin Bandage Rolls

      • Elastic Bandage Rolls

      • Triangular Bandages

      • Orthopedic Bandages

      • Elastic Plaster Bandages

      • Other Bandages

    • Adhesive Tapes

    • Protectives

    • Others

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Diabetes Based surgeries

  • Cardiovascular Disease

  • Ulcers

  • Burns

  • Transplant Sites

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Specialty Clinics

  • Home Healthcare

  • Ambulatory Surgery Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE